董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Lee Shapiro | 男 | Director | 64 | 未披露 | 未持股 | 2021-12-27 |
| Isaac Applbaum | 男 | President and Director | 60 | 未披露 | 未持股 | 2021-12-27 |
| Richard T. Burke | 男 | Chief Executive Officer and Chairman | 77 | 未披露 | 未持股 | 2021-12-27 |
| Ryan Burke | 男 | Chief Financial Officer and Director | 47 | 未披露 | 未持股 | 2021-12-27 |
| Jeffrey A. Leerink | 男 | Director | 56 | 未披露 | 未持股 | 2021-12-27 |
| Mark A. Thierer | 男 | Director | 61 | 未披露 | 未持股 | 2021-12-27 |
| Mark A. Thierer | 男 | Director | 61 | 未披露 | 未持股 | 2021-12-27 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Isaac Applbaum | 男 | President and Director | 60 | 未披露 | 未持股 | 2021-12-27 |
| Richard T. Burke | 男 | Chief Executive Officer and Chairman | 77 | 未披露 | 未持股 | 2021-12-27 |
| Ryan Burke | 男 | Chief Financial Officer and Director | 47 | 未披露 | 未持股 | 2021-12-27 |
| Steven Schwartz | 男 | Executive Vice President of M&A | 57 | 未披露 | 未持股 | 2021-12-27 |
董事简历
中英对照 | 中文 | 英文- Lee Shapiro
-
Lee Shapiro， 他一直担任7wire Ventures公司（他共同创立的一家风险投资公司，从事创新想法和企业家的投资，主要是消费主导型医疗保健和教育技术等领域）的管理合伙人（2013年以来）。此前，他曾担任Allscripts Healthcare Solutions, Inc.（一个上市医疗卫生信息技术公司，Allscripts）总裁（2002年至2012年12月），也曾担任Allscripts公司的首席执行官顾问（2013年1月至2013年6月）。加入Allscripts公司之前，他曾担任Douglas Elliman-Beitler公司（商业办公管理和开发公司）的首席运营官（从1998年到2000年），在那里他曾领导所有美国商业活动，职业生涯中，他也担任SES Properties, Inc.的总裁、City Financial Bancorp的副董事长，并在Barack、Ferrazzano、Kirschbaum、Perlman & Nagelberg从事商法实践。除了任职一些私营公司的董事会，他目前任职于Medidata Solutions, Inc. （一个公开交易的全球生命科学云解决方案的供应商，在那里他担任审计委员会和提名和公司治理委员会的成员）、 Aptus Health, Inc（Merck & Co., Inc.的全资子公司，专业医学团队 的医疗信息、药物样品和移动决策支持工具的网络资源的最大供应商之一，原为Physicians Interactive Holdings, LLC，"PIH"，在那里他主管审计委员会，并担任薪酬委员会的成员）、the American Heart Association的董事会。2009年至2010年，他也曾被任命到伊利诺伊州的经济复苏委员会（the Economic Recovery Commission of the State of Illinois）。他获得The University of Chicago Law School的法学博士学位。
Lee Shapiro, one of our directors, is the Chief Financial Officer of Livongo and Managing Partner at 7Wire, an investment firm he co-founded over a decade ago. Previously, he was President of Allscripts from 2002 to 2012. Mr. Shapiro's responsibilities included the company's strategy, international operations, business development and partnerships, legal, government relations, health plan initiatives and business activities in the areas of analytics and information services. At times during his tenure at Allscripts, he served as the company's Chief Operating Officer leveraging his unique grasp of the business operations across the spectrum of development, sales, marketing, services and support. Mr. Shapiro previously served on the board of directors of Livongo, where he chaired the audit committee and served as a member of the compensation committee. He also was a member of the executive leadership team, with a focus on strategy and business development. Mr. Shapiro served on the board of directors of Medidata Nasdaq: MDSO, where he served on the audit committee and nominating and governance committee, from 2011 until its sale to Dassault in 2019. Mr. Shapiro also served on the board of Tivity (Nasdaq: TVTY), where he chaired the audit committee and served on the compensation committee, from 2015 until May 2020. He also currently serves on the board and committees of various 7Wire portfolio companies. Since 2016 Mr. Shapiro has been a member of the National Board of Directors of the American Heart Association, where he chairs the audit committee and serves on the business operations committee. Mr. Shapiro practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. Mr. Shapiro holds a JD degree from The University of Chicago Law School and a BS in Accounting from the University of Illinois. - Lee Shapiro， 他一直担任7wire Ventures公司（他共同创立的一家风险投资公司，从事创新想法和企业家的投资，主要是消费主导型医疗保健和教育技术等领域）的管理合伙人（2013年以来）。此前，他曾担任Allscripts Healthcare Solutions, Inc.（一个上市医疗卫生信息技术公司，Allscripts）总裁（2002年至2012年12月），也曾担任Allscripts公司的首席执行官顾问（2013年1月至2013年6月）。加入Allscripts公司之前，他曾担任Douglas Elliman-Beitler公司（商业办公管理和开发公司）的首席运营官（从1998年到2000年），在那里他曾领导所有美国商业活动，职业生涯中，他也担任SES Properties, Inc.的总裁、City Financial Bancorp的副董事长，并在Barack、Ferrazzano、Kirschbaum、Perlman & Nagelberg从事商法实践。除了任职一些私营公司的董事会，他目前任职于Medidata Solutions, Inc. （一个公开交易的全球生命科学云解决方案的供应商，在那里他担任审计委员会和提名和公司治理委员会的成员）、 Aptus Health, Inc（Merck & Co., Inc.的全资子公司，专业医学团队 的医疗信息、药物样品和移动决策支持工具的网络资源的最大供应商之一，原为Physicians Interactive Holdings, LLC，"PIH"，在那里他主管审计委员会，并担任薪酬委员会的成员）、the American Heart Association的董事会。2009年至2010年，他也曾被任命到伊利诺伊州的经济复苏委员会（the Economic Recovery Commission of the State of Illinois）。他获得The University of Chicago Law School的法学博士学位。
- Lee Shapiro, one of our directors, is the Chief Financial Officer of Livongo and Managing Partner at 7Wire, an investment firm he co-founded over a decade ago. Previously, he was President of Allscripts from 2002 to 2012. Mr. Shapiro's responsibilities included the company's strategy, international operations, business development and partnerships, legal, government relations, health plan initiatives and business activities in the areas of analytics and information services. At times during his tenure at Allscripts, he served as the company's Chief Operating Officer leveraging his unique grasp of the business operations across the spectrum of development, sales, marketing, services and support. Mr. Shapiro previously served on the board of directors of Livongo, where he chaired the audit committee and served as a member of the compensation committee. He also was a member of the executive leadership team, with a focus on strategy and business development. Mr. Shapiro served on the board of directors of Medidata Nasdaq: MDSO, where he served on the audit committee and nominating and governance committee, from 2011 until its sale to Dassault in 2019. Mr. Shapiro also served on the board of Tivity (Nasdaq: TVTY), where he chaired the audit committee and served on the compensation committee, from 2015 until May 2020. He also currently serves on the board and committees of various 7Wire portfolio companies. Since 2016 Mr. Shapiro has been a member of the National Board of Directors of the American Heart Association, where he chairs the audit committee and serves on the business operations committee. Mr. Shapiro practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. Mr. Shapiro holds a JD degree from The University of Chicago Law School and a BS in Accounting from the University of Illinois.
- Isaac Applbaum
-
Isaac Applbaum是MizMaa的联合创始人和合伙人，MizMaa是一家投资于移动、云和数字医疗领域的以色列初创公司的基金。Applbaum先生还担任8VC在企业软件和医疗技术方面的高级顾问，以及Livongo早期投资者之一的数字医疗风险投资集团7Wire。此外，Applbaum先生是Secure的联合创始人，自2019年1月起担任董事。最后，他自2020年12月起担任Senior Connect的总裁和董事。Applbaum先生还帮助创建了区块链技术公司SecureKey，他自2012年起担任董事会观察员。2013年至2017年，Applbaum先生还是移动支付公司Kili的早期投资者和董事，之后被Square，Inc.收购。2001年至2006年，Applbaum先生是全球风险基金Lightspeed的合伙人。从1997年到2000年，Applbaum先生是一家基于互联网协议的解决方案公司7/24的董事会观察员。1994年至1999年，Applbaum先生是协和航空公司的联合创始人和首席执行官，1994年至1999年，协和航空公司随后被出售给美国银行。阿普尔鲍姆先生持有叶史瓦大学的学士学位。
Isaac Applbaum, our President and a member of our board of directors, is a Co-founder and Partner of MizMaa, a fund which invests in Israeli startup companies in the mobility, cloud and digital healthcare space. Mr. Applbaum is also currently a Special Advisor to EIGHT, a venture fund which invests in enterprise software and healthcare technologies, and 7Wire, a digital healthcare venture group that was one of the early investors in Livongo. In addition, Mr. Applbaum is a co-founder of Secure, where he has been a director since January 2019. Mr. Applbaum also helped found and build SecureKey, a blockchain technologies company, where he currently serves as a board observer, a position he has held since 2012. Mr. Applbaum also served as an early investor and director of mobile payments company Kili from 2013 to 2017 before it was acquired by Square, Inc. From 1997 to 2000 Mr. Applbaum was a board member of 7/24. Mr. Applbaum was a partner at Lightspeed Venture Partners, a global venture fund, from 2001 to 2006. Mr. Applbaum was also a founder and the Chief Executive Officer at Concorde from 1994 to 1999 when it was sold to Bank of America. Mr. Applbaum holds a BA from Yeshiva University. - Isaac Applbaum是MizMaa的联合创始人和合伙人，MizMaa是一家投资于移动、云和数字医疗领域的以色列初创公司的基金。Applbaum先生还担任8VC在企业软件和医疗技术方面的高级顾问，以及Livongo早期投资者之一的数字医疗风险投资集团7Wire。此外，Applbaum先生是Secure的联合创始人，自2019年1月起担任董事。最后，他自2020年12月起担任Senior Connect的总裁和董事。Applbaum先生还帮助创建了区块链技术公司SecureKey，他自2012年起担任董事会观察员。2013年至2017年，Applbaum先生还是移动支付公司Kili的早期投资者和董事，之后被Square，Inc.收购。2001年至2006年，Applbaum先生是全球风险基金Lightspeed的合伙人。从1997年到2000年，Applbaum先生是一家基于互联网协议的解决方案公司7/24的董事会观察员。1994年至1999年，Applbaum先生是协和航空公司的联合创始人和首席执行官，1994年至1999年，协和航空公司随后被出售给美国银行。阿普尔鲍姆先生持有叶史瓦大学的学士学位。
- Isaac Applbaum, our President and a member of our board of directors, is a Co-founder and Partner of MizMaa, a fund which invests in Israeli startup companies in the mobility, cloud and digital healthcare space. Mr. Applbaum is also currently a Special Advisor to EIGHT, a venture fund which invests in enterprise software and healthcare technologies, and 7Wire, a digital healthcare venture group that was one of the early investors in Livongo. In addition, Mr. Applbaum is a co-founder of Secure, where he has been a director since January 2019. Mr. Applbaum also helped found and build SecureKey, a blockchain technologies company, where he currently serves as a board observer, a position he has held since 2012. Mr. Applbaum also served as an early investor and director of mobile payments company Kili from 2013 to 2017 before it was acquired by Square, Inc. From 1997 to 2000 Mr. Applbaum was a board member of 7/24. Mr. Applbaum was a partner at Lightspeed Venture Partners, a global venture fund, from 2001 to 2006. Mr. Applbaum was also a founder and the Chief Executive Officer at Concorde from 1994 to 1999 when it was sold to Bank of America. Mr. Applbaum holds a BA from Yeshiva University.
- Richard T. Burke
-
RichardT.Burke，我们的首席执行官兼董事长，是UnitedHealth的创始人、前首席执行官兼董事长，直到2017年末，目前是UnitedHealth的首席独立董事。直到2000年11月，Burke先生是Phoenix Coyotes的所有者、首席执行官和州长，这是一支国家冰球联盟球队。他曾担任多家私人和上市公司的董事，是许多其他公司的私人投资者，也是拥有和运营多项业务的投资基金Rain的管理合伙人。Burke先生在UnitedHealth任职期间拥有丰富的服务高级市场的经验，他是面向高级客户的企业Secure的主要投资者和执行主席。从2004年到2019年，Burke先生是Meritage Homes Corporation的董事；此前，他也曾任职UnitedHealth，Meritage Homes Corporation和First Cash Financial Services，Inc.的董事会审计委员会。Burke先生拥有Georgia State University的金融MBA学位。Burke先生是我们的首席财务官和董事Ryan Burke的父亲。
Richard T. Burke, our Chief Executive Officer and Chairman, was the founder, former Chief Executive Officer and Chairman until late 2017 and current Lead Independent Director of, UnitedHealth. Until November 2000 Mr. Burke was the owner, Chief Executive Officer and Governor of the Phoenix Coyotes, a National Hockey League team. He has served as a director of numerous private and public companies, is a private investor in many others, and is a Managing Partner at Rainy, an investment fund that owns and operates a number of businesses. Mr. Burke has had extensive experience serving the senior market through his tenure at UnitedHealth, and he is the principal investor in and Executive Chairman of a senior-oriented business, Secure. From 2004 to 2019 Mr. Burke was a director for Meritage Homes Corporation; he also previously served on the audit committees of the board of directors of UnitedHealth, Meritage Homes Corporation and First Cash Financial Services, Inc. Mr. Burke holds a MBA in Finance from Georgia State University. Mr. Burke is the father of Ryan Burke, our Chief Financial Officer and a director. - RichardT.Burke，我们的首席执行官兼董事长，是UnitedHealth的创始人、前首席执行官兼董事长，直到2017年末，目前是UnitedHealth的首席独立董事。直到2000年11月，Burke先生是Phoenix Coyotes的所有者、首席执行官和州长，这是一支国家冰球联盟球队。他曾担任多家私人和上市公司的董事，是许多其他公司的私人投资者，也是拥有和运营多项业务的投资基金Rain的管理合伙人。Burke先生在UnitedHealth任职期间拥有丰富的服务高级市场的经验，他是面向高级客户的企业Secure的主要投资者和执行主席。从2004年到2019年，Burke先生是Meritage Homes Corporation的董事；此前，他也曾任职UnitedHealth，Meritage Homes Corporation和First Cash Financial Services，Inc.的董事会审计委员会。Burke先生拥有Georgia State University的金融MBA学位。Burke先生是我们的首席财务官和董事Ryan Burke的父亲。
- Richard T. Burke, our Chief Executive Officer and Chairman, was the founder, former Chief Executive Officer and Chairman until late 2017 and current Lead Independent Director of, UnitedHealth. Until November 2000 Mr. Burke was the owner, Chief Executive Officer and Governor of the Phoenix Coyotes, a National Hockey League team. He has served as a director of numerous private and public companies, is a private investor in many others, and is a Managing Partner at Rainy, an investment fund that owns and operates a number of businesses. Mr. Burke has had extensive experience serving the senior market through his tenure at UnitedHealth, and he is the principal investor in and Executive Chairman of a senior-oriented business, Secure. From 2004 to 2019 Mr. Burke was a director for Meritage Homes Corporation; he also previously served on the audit committees of the board of directors of UnitedHealth, Meritage Homes Corporation and First Cash Financial Services, Inc. Mr. Burke holds a MBA in Finance from Georgia State University. Mr. Burke is the father of Ryan Burke, our Chief Financial Officer and a director.
- Ryan Burke
-
Ryan Burke，我们的首席财务官，自2008年起担任Rain的首席投资官，在那里他评估所有新的投资机会，并帮助管理Rain’；的私人投资、上市证券和经营业务的投资组合。Burke先生目前是BFO，LLC的首席投资官，该公司是总部位于纽约的对冲基金Prime Macaya Capital Management，LP的合伙人。在其最近被出售给Galaxy Digital Holdings之前，他也是Blue Fire Capital的合伙人和董事，该公司是一家专有交易公司和全球流动性提供商，专注于加密货币。Burke先生目前担任Secure的代理首席财务官，此前曾担任多个Rain Portfolio Company的首席财务官。2008年之前，他曾担任Alpine的投资组合经理兼首席风险官，这是一家总部位于纽约的多空对冲基金。伯克的职业生涯始于担任摩根资本（Morgan Capital）的金融分析师，这是一家当时规模为19亿美元的私募股权基金。Burke先生拥有福库商学院工商管理硕士学位和杜克大学学士学位。Burke先生是我们的首席执行官兼董事长RichardT.Burke的儿子。
Ryan Burke, our Chief Financial Officer, has been Chief Investment Officer for Rainy since 2008 where he evaluates all new investment opportunities and helps manage Rainy's portfolio of private investments, publicly traded securities, and operating businesses. Mr. Burke is currently Chief Investment Officer of BFO, LLC, a Partner at Prime Macaya Capital Management, LP, a New York-based hedge fund. Prior to its recent sale to Galaxy Digital Holdings, he was also a partner and director at Blue Fire Capital, a proprietary trading firm and global liquidity provider specializing in cryptocurrencies. Mr. Burke is currently acting Chief Financial Officer of Secure, and previously served as Chief Financial Officer for various Rainy portfolio companies. Prior to 2008 he was a Portfolio Manager and Chief Risk Officer at Alpine, a New York-based long-short hedge fund. Mr. Burke began his career as a financial analyst at Morgan Capital, a then $1.9 billion private equity fund. Mr. Burke holds a master's degree in business administration from the Fuqua School of Business and a bachelor's degree from Duke University. Mr. Burke is the son of Richard T. Burke, our Chief Executive Officer and Chairman. - Ryan Burke，我们的首席财务官，自2008年起担任Rain的首席投资官，在那里他评估所有新的投资机会，并帮助管理Rain’；的私人投资、上市证券和经营业务的投资组合。Burke先生目前是BFO，LLC的首席投资官，该公司是总部位于纽约的对冲基金Prime Macaya Capital Management，LP的合伙人。在其最近被出售给Galaxy Digital Holdings之前，他也是Blue Fire Capital的合伙人和董事，该公司是一家专有交易公司和全球流动性提供商，专注于加密货币。Burke先生目前担任Secure的代理首席财务官，此前曾担任多个Rain Portfolio Company的首席财务官。2008年之前，他曾担任Alpine的投资组合经理兼首席风险官，这是一家总部位于纽约的多空对冲基金。伯克的职业生涯始于担任摩根资本（Morgan Capital）的金融分析师，这是一家当时规模为19亿美元的私募股权基金。Burke先生拥有福库商学院工商管理硕士学位和杜克大学学士学位。Burke先生是我们的首席执行官兼董事长RichardT.Burke的儿子。
- Ryan Burke, our Chief Financial Officer, has been Chief Investment Officer for Rainy since 2008 where he evaluates all new investment opportunities and helps manage Rainy's portfolio of private investments, publicly traded securities, and operating businesses. Mr. Burke is currently Chief Investment Officer of BFO, LLC, a Partner at Prime Macaya Capital Management, LP, a New York-based hedge fund. Prior to its recent sale to Galaxy Digital Holdings, he was also a partner and director at Blue Fire Capital, a proprietary trading firm and global liquidity provider specializing in cryptocurrencies. Mr. Burke is currently acting Chief Financial Officer of Secure, and previously served as Chief Financial Officer for various Rainy portfolio companies. Prior to 2008 he was a Portfolio Manager and Chief Risk Officer at Alpine, a New York-based long-short hedge fund. Mr. Burke began his career as a financial analyst at Morgan Capital, a then $1.9 billion private equity fund. Mr. Burke holds a master's degree in business administration from the Fuqua School of Business and a bachelor's degree from Duke University. Mr. Burke is the son of Richard T. Burke, our Chief Executive Officer and Chairman.
- Jeffrey A. Leerink
-
Jeffrey A.Leerink是我们的董事之一，目前是SVB Leerink的首席执行官，这是一家服务于医疗保健行业的领先投资银行。Leerink先生于1995年创立了Leerink Partners；在Leerink先生的领导下，Leerink Partners联合创立了一家私募股权公司，专注于医疗保健行业，该公司由两家基金公司组成；Leerink Transformation Partners，专注于投资于技术驱动型医疗保健公司，以及Leerink Revelation Partners，一种二级投资基金，主要投资于具有成熟商业模式的商业公司或具有新技术的公司。2008年，Leerink先生联合创立了Humedica，Inc.，并担任其董事会成员。Leerink先生目前在FogPharma的董事会任职。此外，Leerink先生目前担任哈佛医学院研究员委员会成员。Leerink先生拥有联合学院经济学学士学位。
Jeffrey A. Leerink, one of our directors, is currently the Chief Executive Officer of SVB Leerink, a leading investment bank serving the healthcare industry. Mr. Leerink founded Leerink Partners in 1995; under Mr. Leerink's leadership, Leerink Partners co-founded a private equity business focused on the healthcare industry that consisted of two fund companies; Leerink Transformation Partners, focused on investing in technology-enabled healthcare companies, and Leerink Revelation Partners, a secondary investment fund focused on commercial companies with proven business models or companies with novel technologies. In 2008 Mr. Leerink co-founded and was a member of the board of directors of Humedica, Inc. Mr. Leerink currently serves on the board of directors of FogPharma. Additionally, Mr. Leerink currently serves as a member of the Harvard Medical School Board of Fellows. Mr. Leerink holds a BA in Economics from Union College. - Jeffrey A.Leerink是我们的董事之一，目前是SVB Leerink的首席执行官，这是一家服务于医疗保健行业的领先投资银行。Leerink先生于1995年创立了Leerink Partners；在Leerink先生的领导下，Leerink Partners联合创立了一家私募股权公司，专注于医疗保健行业，该公司由两家基金公司组成；Leerink Transformation Partners，专注于投资于技术驱动型医疗保健公司，以及Leerink Revelation Partners，一种二级投资基金，主要投资于具有成熟商业模式的商业公司或具有新技术的公司。2008年，Leerink先生联合创立了Humedica，Inc.，并担任其董事会成员。Leerink先生目前在FogPharma的董事会任职。此外，Leerink先生目前担任哈佛医学院研究员委员会成员。Leerink先生拥有联合学院经济学学士学位。
- Jeffrey A. Leerink, one of our directors, is currently the Chief Executive Officer of SVB Leerink, a leading investment bank serving the healthcare industry. Mr. Leerink founded Leerink Partners in 1995; under Mr. Leerink's leadership, Leerink Partners co-founded a private equity business focused on the healthcare industry that consisted of two fund companies; Leerink Transformation Partners, focused on investing in technology-enabled healthcare companies, and Leerink Revelation Partners, a secondary investment fund focused on commercial companies with proven business models or companies with novel technologies. In 2008 Mr. Leerink co-founded and was a member of the board of directors of Humedica, Inc. Mr. Leerink currently serves on the board of directors of FogPharma. Additionally, Mr. Leerink currently serves as a member of the Harvard Medical School Board of Fellows. Mr. Leerink holds a BA in Economics from Union College.
- Mark A. Thierer
-
Mark A. Thierer自2021年12月起担任P3 Health Partners Inc.董事，自2020年10月起担任Foresight顾问。Thierer先生目前担任他所成立的投资公司AssetBlue Investment Group的管理合伙人，自2017年6月起担任该职位。2017年10月至2018年2月，Thierer先生还担任登士柏西诺德公司（纳斯达克股票代码：XRAY）的临时首席执行官，登士柏西诺德公司是一家种植牙制造商。2015年7月至2017年9月，Thierer先生担任药房护理服务公司OptumRx的首席执行官。此前，他曾在Catamaran Corporation（Nasdaq：CTRX）担任董事长兼首席执行官，Catamaran Corporation是美国最大的药房福利管理公司之一，2011年3月至2015年与OptumRx合并。Thierer先生曾担任首席执行官，领导过一家全国性的药房福利和医疗保健信息技术解决方案公司。他的技能包括战略和业务发展、技术、金融和市场营销。Thierer在组织和执行包括兼并和收购在内的战略性公司交易方面也有经验。Thierer先生自2014年起担任Discover Financial Services（纽约证券交易所代码：DFS）和Senior Connect收购公司（纳斯达克代码：SNRH）的董事会成员。Thierer先生在明尼苏达大学获得金融学学士学位，在新东南大学获得工商管理硕士学位。Thierer先生还拥有宾夕法尼亚大学沃顿商学院的CEBS（认证员工福利专家）称号。
Mark A. Thierer,has served as a Director of the Company since December 2021 and an advisor to Foresight Acquisition Corp. since October 2020. Mr. Thierer currently serves as the managing partner of the investment firm he formed, AssetBlue Investment Group, a position he has held since June 2017. From October 2017 through February 2018, Mr. Thierer also served as the interim Chief Executive Officer of Dentsply Sirona Inc. (Nasdaq: XRAY), a manufacturer of dental implants. Mr. Thierer was Chief Executive Officer of OptumRx, a pharmacy care services company, from July 2015 until September 2017. He previously served as chairman and Chief Executive Officer of Catamaran Corporation (Nasdaq: CTRX), one of the nation's largest pharmacy benefit management companies, from March 2011 until it combined with OptumRx in 2015. Mr. Thierer has experience as a Chief Executive Officer leading a national pharmacy benefit and healthcare information technology solutions company. His skills include strategy and business development, technology, finance and marketing.Mr. Thierer also has experience in the structuring and execution of strategic corporate transactions, including mergers and acquisitions. Mr. Thierer is a member of the board of directors of Discover Financial Services (NYSE: DFS) since 2014 and Senior Connect Acquisition Corp. (Nasdaq: SNRH). Mr. Thierer received a BS in Finance from the University of Minnesota and an MBA from Nova Southeastern University. Mr. Thierer also holds the designation of CEBS (Certified Employee Benefits Specialist) from The Wharton School of the University of Pennsylvania. - Mark A. Thierer自2021年12月起担任P3 Health Partners Inc.董事，自2020年10月起担任Foresight顾问。Thierer先生目前担任他所成立的投资公司AssetBlue Investment Group的管理合伙人，自2017年6月起担任该职位。2017年10月至2018年2月，Thierer先生还担任登士柏西诺德公司（纳斯达克股票代码：XRAY）的临时首席执行官，登士柏西诺德公司是一家种植牙制造商。2015年7月至2017年9月，Thierer先生担任药房护理服务公司OptumRx的首席执行官。此前，他曾在Catamaran Corporation（Nasdaq：CTRX）担任董事长兼首席执行官，Catamaran Corporation是美国最大的药房福利管理公司之一，2011年3月至2015年与OptumRx合并。Thierer先生曾担任首席执行官，领导过一家全国性的药房福利和医疗保健信息技术解决方案公司。他的技能包括战略和业务发展、技术、金融和市场营销。Thierer在组织和执行包括兼并和收购在内的战略性公司交易方面也有经验。Thierer先生自2014年起担任Discover Financial Services（纽约证券交易所代码：DFS）和Senior Connect收购公司（纳斯达克代码：SNRH）的董事会成员。Thierer先生在明尼苏达大学获得金融学学士学位，在新东南大学获得工商管理硕士学位。Thierer先生还拥有宾夕法尼亚大学沃顿商学院的CEBS（认证员工福利专家）称号。
- Mark A. Thierer,has served as a Director of the Company since December 2021 and an advisor to Foresight Acquisition Corp. since October 2020. Mr. Thierer currently serves as the managing partner of the investment firm he formed, AssetBlue Investment Group, a position he has held since June 2017. From October 2017 through February 2018, Mr. Thierer also served as the interim Chief Executive Officer of Dentsply Sirona Inc. (Nasdaq: XRAY), a manufacturer of dental implants. Mr. Thierer was Chief Executive Officer of OptumRx, a pharmacy care services company, from July 2015 until September 2017. He previously served as chairman and Chief Executive Officer of Catamaran Corporation (Nasdaq: CTRX), one of the nation's largest pharmacy benefit management companies, from March 2011 until it combined with OptumRx in 2015. Mr. Thierer has experience as a Chief Executive Officer leading a national pharmacy benefit and healthcare information technology solutions company. His skills include strategy and business development, technology, finance and marketing.Mr. Thierer also has experience in the structuring and execution of strategic corporate transactions, including mergers and acquisitions. Mr. Thierer is a member of the board of directors of Discover Financial Services (NYSE: DFS) since 2014 and Senior Connect Acquisition Corp. (Nasdaq: SNRH). Mr. Thierer received a BS in Finance from the University of Minnesota and an MBA from Nova Southeastern University. Mr. Thierer also holds the designation of CEBS (Certified Employee Benefits Specialist) from The Wharton School of the University of Pennsylvania.
- Mark A. Thierer
-
Mark A. Thierer，他现任Catamaran Corporation董事长兼首席执行官，同时出任该公司董事。Catamaran Corporation是一家提供药品福利管理服务及医疗信息技术解决方案的公司。2006年至2008年，他曾任Catamaran Corporation总裁兼首席运营官；2008年至2011年，曾任Catamaran Corporation总裁兼首席执行官。
Mark A. Thierer currently serves as the managing partner of AssetBlue Investment Group, a position he has held since June 2017. From October 2017 through February 2018 Mr. Thierer also served as the interim chief executive officer of Dentsply Sirona Inc., a manufacturer of dental implants. Mr. Thierer was chief executive officer of OptumRx, a pharmacy care services company, from July 2015 until September 2017. He previously served as chairman and chief executive officer of Catamaran Corporation, one of the nation's largest pharmacy benefit management companies, from March 2011 until it combined with OptumRx in 2015. - Mark A. Thierer，他现任Catamaran Corporation董事长兼首席执行官，同时出任该公司董事。Catamaran Corporation是一家提供药品福利管理服务及医疗信息技术解决方案的公司。2006年至2008年，他曾任Catamaran Corporation总裁兼首席运营官；2008年至2011年，曾任Catamaran Corporation总裁兼首席执行官。
- Mark A. Thierer currently serves as the managing partner of AssetBlue Investment Group, a position he has held since June 2017. From October 2017 through February 2018 Mr. Thierer also served as the interim chief executive officer of Dentsply Sirona Inc., a manufacturer of dental implants. Mr. Thierer was chief executive officer of OptumRx, a pharmacy care services company, from July 2015 until September 2017. He previously served as chairman and chief executive officer of Catamaran Corporation, one of the nation's largest pharmacy benefit management companies, from March 2011 until it combined with OptumRx in 2015.
高管简历
中英对照 | 中文 | 英文- Isaac Applbaum
Isaac Applbaum是MizMaa的联合创始人和合伙人，MizMaa是一家投资于移动、云和数字医疗领域的以色列初创公司的基金。Applbaum先生还担任8VC在企业软件和医疗技术方面的高级顾问，以及Livongo早期投资者之一的数字医疗风险投资集团7Wire。此外，Applbaum先生是Secure的联合创始人，自2019年1月起担任董事。最后，他自2020年12月起担任Senior Connect的总裁和董事。Applbaum先生还帮助创建了区块链技术公司SecureKey，他自2012年起担任董事会观察员。2013年至2017年，Applbaum先生还是移动支付公司Kili的早期投资者和董事，之后被Square，Inc.收购。2001年至2006年，Applbaum先生是全球风险基金Lightspeed的合伙人。从1997年到2000年，Applbaum先生是一家基于互联网协议的解决方案公司7/24的董事会观察员。1994年至1999年，Applbaum先生是协和航空公司的联合创始人和首席执行官，1994年至1999年，协和航空公司随后被出售给美国银行。阿普尔鲍姆先生持有叶史瓦大学的学士学位。
Isaac Applbaum, our President and a member of our board of directors, is a Co-founder and Partner of MizMaa, a fund which invests in Israeli startup companies in the mobility, cloud and digital healthcare space. Mr. Applbaum is also currently a Special Advisor to EIGHT, a venture fund which invests in enterprise software and healthcare technologies, and 7Wire, a digital healthcare venture group that was one of the early investors in Livongo. In addition, Mr. Applbaum is a co-founder of Secure, where he has been a director since January 2019. Mr. Applbaum also helped found and build SecureKey, a blockchain technologies company, where he currently serves as a board observer, a position he has held since 2012. Mr. Applbaum also served as an early investor and director of mobile payments company Kili from 2013 to 2017 before it was acquired by Square, Inc. From 1997 to 2000 Mr. Applbaum was a board member of 7/24. Mr. Applbaum was a partner at Lightspeed Venture Partners, a global venture fund, from 2001 to 2006. Mr. Applbaum was also a founder and the Chief Executive Officer at Concorde from 1994 to 1999 when it was sold to Bank of America. Mr. Applbaum holds a BA from Yeshiva University.- Isaac Applbaum是MizMaa的联合创始人和合伙人，MizMaa是一家投资于移动、云和数字医疗领域的以色列初创公司的基金。Applbaum先生还担任8VC在企业软件和医疗技术方面的高级顾问，以及Livongo早期投资者之一的数字医疗风险投资集团7Wire。此外，Applbaum先生是Secure的联合创始人，自2019年1月起担任董事。最后，他自2020年12月起担任Senior Connect的总裁和董事。Applbaum先生还帮助创建了区块链技术公司SecureKey，他自2012年起担任董事会观察员。2013年至2017年，Applbaum先生还是移动支付公司Kili的早期投资者和董事，之后被Square，Inc.收购。2001年至2006年，Applbaum先生是全球风险基金Lightspeed的合伙人。从1997年到2000年，Applbaum先生是一家基于互联网协议的解决方案公司7/24的董事会观察员。1994年至1999年，Applbaum先生是协和航空公司的联合创始人和首席执行官，1994年至1999年，协和航空公司随后被出售给美国银行。阿普尔鲍姆先生持有叶史瓦大学的学士学位。
- Isaac Applbaum, our President and a member of our board of directors, is a Co-founder and Partner of MizMaa, a fund which invests in Israeli startup companies in the mobility, cloud and digital healthcare space. Mr. Applbaum is also currently a Special Advisor to EIGHT, a venture fund which invests in enterprise software and healthcare technologies, and 7Wire, a digital healthcare venture group that was one of the early investors in Livongo. In addition, Mr. Applbaum is a co-founder of Secure, where he has been a director since January 2019. Mr. Applbaum also helped found and build SecureKey, a blockchain technologies company, where he currently serves as a board observer, a position he has held since 2012. Mr. Applbaum also served as an early investor and director of mobile payments company Kili from 2013 to 2017 before it was acquired by Square, Inc. From 1997 to 2000 Mr. Applbaum was a board member of 7/24. Mr. Applbaum was a partner at Lightspeed Venture Partners, a global venture fund, from 2001 to 2006. Mr. Applbaum was also a founder and the Chief Executive Officer at Concorde from 1994 to 1999 when it was sold to Bank of America. Mr. Applbaum holds a BA from Yeshiva University.
- Richard T. Burke
RichardT.Burke，我们的首席执行官兼董事长，是UnitedHealth的创始人、前首席执行官兼董事长，直到2017年末，目前是UnitedHealth的首席独立董事。直到2000年11月，Burke先生是Phoenix Coyotes的所有者、首席执行官和州长，这是一支国家冰球联盟球队。他曾担任多家私人和上市公司的董事，是许多其他公司的私人投资者，也是拥有和运营多项业务的投资基金Rain的管理合伙人。Burke先生在UnitedHealth任职期间拥有丰富的服务高级市场的经验，他是面向高级客户的企业Secure的主要投资者和执行主席。从2004年到2019年，Burke先生是Meritage Homes Corporation的董事；此前，他也曾任职UnitedHealth，Meritage Homes Corporation和First Cash Financial Services，Inc.的董事会审计委员会。Burke先生拥有Georgia State University的金融MBA学位。Burke先生是我们的首席财务官和董事Ryan Burke的父亲。
Richard T. Burke, our Chief Executive Officer and Chairman, was the founder, former Chief Executive Officer and Chairman until late 2017 and current Lead Independent Director of, UnitedHealth. Until November 2000 Mr. Burke was the owner, Chief Executive Officer and Governor of the Phoenix Coyotes, a National Hockey League team. He has served as a director of numerous private and public companies, is a private investor in many others, and is a Managing Partner at Rainy, an investment fund that owns and operates a number of businesses. Mr. Burke has had extensive experience serving the senior market through his tenure at UnitedHealth, and he is the principal investor in and Executive Chairman of a senior-oriented business, Secure. From 2004 to 2019 Mr. Burke was a director for Meritage Homes Corporation; he also previously served on the audit committees of the board of directors of UnitedHealth, Meritage Homes Corporation and First Cash Financial Services, Inc. Mr. Burke holds a MBA in Finance from Georgia State University. Mr. Burke is the father of Ryan Burke, our Chief Financial Officer and a director.- RichardT.Burke，我们的首席执行官兼董事长，是UnitedHealth的创始人、前首席执行官兼董事长，直到2017年末，目前是UnitedHealth的首席独立董事。直到2000年11月，Burke先生是Phoenix Coyotes的所有者、首席执行官和州长，这是一支国家冰球联盟球队。他曾担任多家私人和上市公司的董事，是许多其他公司的私人投资者，也是拥有和运营多项业务的投资基金Rain的管理合伙人。Burke先生在UnitedHealth任职期间拥有丰富的服务高级市场的经验，他是面向高级客户的企业Secure的主要投资者和执行主席。从2004年到2019年，Burke先生是Meritage Homes Corporation的董事；此前，他也曾任职UnitedHealth，Meritage Homes Corporation和First Cash Financial Services，Inc.的董事会审计委员会。Burke先生拥有Georgia State University的金融MBA学位。Burke先生是我们的首席财务官和董事Ryan Burke的父亲。
- Richard T. Burke, our Chief Executive Officer and Chairman, was the founder, former Chief Executive Officer and Chairman until late 2017 and current Lead Independent Director of, UnitedHealth. Until November 2000 Mr. Burke was the owner, Chief Executive Officer and Governor of the Phoenix Coyotes, a National Hockey League team. He has served as a director of numerous private and public companies, is a private investor in many others, and is a Managing Partner at Rainy, an investment fund that owns and operates a number of businesses. Mr. Burke has had extensive experience serving the senior market through his tenure at UnitedHealth, and he is the principal investor in and Executive Chairman of a senior-oriented business, Secure. From 2004 to 2019 Mr. Burke was a director for Meritage Homes Corporation; he also previously served on the audit committees of the board of directors of UnitedHealth, Meritage Homes Corporation and First Cash Financial Services, Inc. Mr. Burke holds a MBA in Finance from Georgia State University. Mr. Burke is the father of Ryan Burke, our Chief Financial Officer and a director.
- Ryan Burke
Ryan Burke，我们的首席财务官，自2008年起担任Rain的首席投资官，在那里他评估所有新的投资机会，并帮助管理Rain’；的私人投资、上市证券和经营业务的投资组合。Burke先生目前是BFO，LLC的首席投资官，该公司是总部位于纽约的对冲基金Prime Macaya Capital Management，LP的合伙人。在其最近被出售给Galaxy Digital Holdings之前，他也是Blue Fire Capital的合伙人和董事，该公司是一家专有交易公司和全球流动性提供商，专注于加密货币。Burke先生目前担任Secure的代理首席财务官，此前曾担任多个Rain Portfolio Company的首席财务官。2008年之前，他曾担任Alpine的投资组合经理兼首席风险官，这是一家总部位于纽约的多空对冲基金。伯克的职业生涯始于担任摩根资本（Morgan Capital）的金融分析师，这是一家当时规模为19亿美元的私募股权基金。Burke先生拥有福库商学院工商管理硕士学位和杜克大学学士学位。Burke先生是我们的首席执行官兼董事长RichardT.Burke的儿子。
Ryan Burke, our Chief Financial Officer, has been Chief Investment Officer for Rainy since 2008 where he evaluates all new investment opportunities and helps manage Rainy's portfolio of private investments, publicly traded securities, and operating businesses. Mr. Burke is currently Chief Investment Officer of BFO, LLC, a Partner at Prime Macaya Capital Management, LP, a New York-based hedge fund. Prior to its recent sale to Galaxy Digital Holdings, he was also a partner and director at Blue Fire Capital, a proprietary trading firm and global liquidity provider specializing in cryptocurrencies. Mr. Burke is currently acting Chief Financial Officer of Secure, and previously served as Chief Financial Officer for various Rainy portfolio companies. Prior to 2008 he was a Portfolio Manager and Chief Risk Officer at Alpine, a New York-based long-short hedge fund. Mr. Burke began his career as a financial analyst at Morgan Capital, a then $1.9 billion private equity fund. Mr. Burke holds a master's degree in business administration from the Fuqua School of Business and a bachelor's degree from Duke University. Mr. Burke is the son of Richard T. Burke, our Chief Executive Officer and Chairman.- Ryan Burke，我们的首席财务官，自2008年起担任Rain的首席投资官，在那里他评估所有新的投资机会，并帮助管理Rain’；的私人投资、上市证券和经营业务的投资组合。Burke先生目前是BFO，LLC的首席投资官，该公司是总部位于纽约的对冲基金Prime Macaya Capital Management，LP的合伙人。在其最近被出售给Galaxy Digital Holdings之前，他也是Blue Fire Capital的合伙人和董事，该公司是一家专有交易公司和全球流动性提供商，专注于加密货币。Burke先生目前担任Secure的代理首席财务官，此前曾担任多个Rain Portfolio Company的首席财务官。2008年之前，他曾担任Alpine的投资组合经理兼首席风险官，这是一家总部位于纽约的多空对冲基金。伯克的职业生涯始于担任摩根资本（Morgan Capital）的金融分析师，这是一家当时规模为19亿美元的私募股权基金。Burke先生拥有福库商学院工商管理硕士学位和杜克大学学士学位。Burke先生是我们的首席执行官兼董事长RichardT.Burke的儿子。
- Ryan Burke, our Chief Financial Officer, has been Chief Investment Officer for Rainy since 2008 where he evaluates all new investment opportunities and helps manage Rainy's portfolio of private investments, publicly traded securities, and operating businesses. Mr. Burke is currently Chief Investment Officer of BFO, LLC, a Partner at Prime Macaya Capital Management, LP, a New York-based hedge fund. Prior to its recent sale to Galaxy Digital Holdings, he was also a partner and director at Blue Fire Capital, a proprietary trading firm and global liquidity provider specializing in cryptocurrencies. Mr. Burke is currently acting Chief Financial Officer of Secure, and previously served as Chief Financial Officer for various Rainy portfolio companies. Prior to 2008 he was a Portfolio Manager and Chief Risk Officer at Alpine, a New York-based long-short hedge fund. Mr. Burke began his career as a financial analyst at Morgan Capital, a then $1.9 billion private equity fund. Mr. Burke holds a master's degree in business administration from the Fuqua School of Business and a bachelor's degree from Duke University. Mr. Burke is the son of Richard T. Burke, our Chief Executive Officer and Chairman.
- Steven Schwartz
Steven Schwartz，我们的并购执行副总裁，为团队带来超过30年的数字健康行业交易经验。在过去的四年中，他曾担任Livongo业务和企业发展的高级副总裁，在那里他负责一系列收购，最终以Livongo与Teladoc185亿美元的合并而告终。此前，Schwartz先生在Tivity担任公司发展和战略高级副总裁，此前在23andMe，Inc.担任公司发展和战略职位。在职业生涯早期，Schwartz先生在Allscripts担任了14年的商业和企业发展的执行领导职务，在LabCorp担任了10年的高级管理职务。Schwartz先生目前担任Illuma Care Connections和Kline Galland Senior Care Organization的董事会成员。Schwartz先生拥有华盛顿大学Michael G.Foster商学院工商管理学士学位和华盛顿大学心理学学士学位。
Steven Schwartz, our Executive Vice President of M&A. For the past four years Mr. Schwartz was the Senior Vice President of business and corporate development at Livongo, where he was responsible for the series acquisitions which culminated in Livongo's $18.5 billion merger with Teladoc. Previously, Mr. Schwartz held Senior Vice President of corporate development and strategy roles at Tivity and prior to that at 23andMe, Inc. Earlier in his career Mr. Schwartz held executive leadership positions in business and corporate development at Allscripts for 14 years, and senior management roles at LabCorp for 10 years. Mr. Schwartz currently serves on the board of directors of illuma Care Connections and the Kline Galland senior care organization. Mr. Schwartz holds a BA in business administration from the Michael G. Foster School of Business at the University of Washington and a BA in psychology also from the University of Washington.- Steven Schwartz，我们的并购执行副总裁，为团队带来超过30年的数字健康行业交易经验。在过去的四年中，他曾担任Livongo业务和企业发展的高级副总裁，在那里他负责一系列收购，最终以Livongo与Teladoc185亿美元的合并而告终。此前，Schwartz先生在Tivity担任公司发展和战略高级副总裁，此前在23andMe，Inc.担任公司发展和战略职位。在职业生涯早期，Schwartz先生在Allscripts担任了14年的商业和企业发展的执行领导职务，在LabCorp担任了10年的高级管理职务。Schwartz先生目前担任Illuma Care Connections和Kline Galland Senior Care Organization的董事会成员。Schwartz先生拥有华盛顿大学Michael G.Foster商学院工商管理学士学位和华盛顿大学心理学学士学位。
- Steven Schwartz, our Executive Vice President of M&A. For the past four years Mr. Schwartz was the Senior Vice President of business and corporate development at Livongo, where he was responsible for the series acquisitions which culminated in Livongo's $18.5 billion merger with Teladoc. Previously, Mr. Schwartz held Senior Vice President of corporate development and strategy roles at Tivity and prior to that at 23andMe, Inc. Earlier in his career Mr. Schwartz held executive leadership positions in business and corporate development at Allscripts for 14 years, and senior management roles at LabCorp for 10 years. Mr. Schwartz currently serves on the board of directors of illuma Care Connections and the Kline Galland senior care organization. Mr. Schwartz holds a BA in business administration from the Michael G. Foster School of Business at the University of Washington and a BA in psychology also from the University of Washington.